Nov 27 2020;25(23)doi:10.3390/molecules25235566
We should approach these compounds cautiously and consult a medical professional before use
Looking ahead, the future of GLP-1RA delivery is poised to include oral, ultralong-acting injectables, implantable pumps, smart electronic devices, and noninvasive systems like sublingual or transdermal routes
By improving patients' weight loss and loss of appetite, their quality of life can be enhanced
Do not use compounded semaglutide if: You have or had an eating disorder such as binge eating disorder, anorexia nervosa or bulimia
N Engl J Med 375:18341844 Kosiborod MN, Abildstrm SZ, Borlaug BA et al (2023) Semaglutide in patients with heart failure with preserved ejection fraction and obesity